Project Grant R01NS144169
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Johns Hopkins University a $155,000 project grant effective July 8, 2025 through June 30, 2027 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). The award supports the characterization of an aminoacyl-tRNA synthetase complex interacting multifunctional protein-2 (AIMP2) variant-linked mouse model of Parkinson's disease. The...
- Federal Grant Award Summary Purdue University received a $431,750 Project Grant award from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), effective September 5, 2025, through August 31, 2027. The project, titled "Building Vocabulary Networks," will deliver research services focused on understanding early language development and vocabulary acquisition in toddlers,...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Johns Hopkins University a $426,875 Project Grant effective August 1, 2025 through July 31, 2027 under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The award funds research to develop the marmoset primate model for studying cerebellar control of tongue movements, a critical gap in understanding how the cerebellum...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded UCLA a $460,563 Project Grant effective August 1, 2025, through July 31, 2027, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This award supports research and development activities focused on translating ProSAAS (Progranulin-derived Secreted Protein Associated with Synapses), a brain-specific cellular chaperone, into a therapeutic...
- Federal Grant Award Summary New York University School of Medicine received a $164,516 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective May 1, 2025, through April 30, 2027. This award funds research investigating the neural mechanisms underlying speech planning and its relationship to neurological disorders, specifically Parkinson's disease...
- Federal Grant Award Summary Emory University received a $540,901 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective April 15, 2026, through March 31, 2031. The grant supports a five-year research initiative investigating changes in molecular mechanisms of dopamine signaling in advanced Parkinson's disease (PD), with particular focus...
- Federal Grant Award Summary Purdue University received a $159,116 Project Grant from the National Institute on Deafness and Other Communication Disorders (NIDCD) under the Research Related to Deafness and Communication Disorders program (CFDA 93.173), awarded September 30, 2025, with completion scheduled for September 29, 2026. The research project, titled "Predicting Phonological Outcomes in Late Talkers: The Role of Speech Perception and Production Skills," investigates patterns of...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded the University of Florida a Project Grant totaling $114,102 (awarded May 4, 2026; completion date April 30, 2028) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This award supports a K99/R00 career development grant for an early-career investigator conducting translational neuroscience research on L-DOPA-induced dyskinesia (LID) in...
- Federal Project Grant Summary Northwestern University's Sponsored Research Division received a $566,529 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective April 24, 2026, with completion targeted for March 31, 2031. This research initiative investigates age-related deficits in trophic support of dopamine neurons in preclinical models of...
- Federal Grant Award Summary The University of Illinois received a $225,474 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded June 1, 2026, with a completion date of May 31, 2027. The grant funds the development of a base editing gene therapy to treat Parkinson's Disease by modulating the LRRK2 gene. The research delivers two primary...
Purdue University received a $583,633 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 1, 2026 through May 31, 2031. The award funds preclinical research investigating region-specific effects of pathology and vocal training on vocalization deficits in a mouse model of Parkinson's disease. The research addresses a critical gap in understanding voice and communication impairments that occur early in Parkinson's disease but remain poorly understood at the mechanistic level and unresponsive to current treatments targeting the nigrostriatal dopaminergic system. The project will utilize a preclinical mouse model enabling region-specific induction of pathology within discrete areas of the nigrostriatal and cranial sensorimotor systems to determine which vocalization deficits result from pathology in each system and how vocal training modulates these deficits. Deliverables will include fundamental mechanistic insights into the neurophysiological pathways underlying early voice and communication deficits in Parkinson's disease, with results intended to inform development of novel diagnostic and therapeutic approaches for treating these debilitating symptoms that significantly impact patient quality of life, social function, and caregiver burden.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $583.6k | 6/3/26 |